"LVPG Hematology Oncology–Muhlenberg is part of Lehigh Valley Topper Cancer Institute, a national leader in cancer care and a member of the Memorial Sloan Kettering Cancer Alliance. We care for individuals with cancer and blood-related diseases in a friendly, relaxed and confidential environment. We serve as patient advocates, working with our community partners to provide the best quality of life to those with cancer and their caregivers. Programs offered here include clinical trials, a variety of diagnostic, treatment and supportive care programs."

During the past decade, Oncology-Hematology of Lehigh Valley PC conducted 0 clinical trials. In the 10-year time frame, 0 clinical trials started and 2 clinical trials were completed, i.e. on average, 0% percent of trials that started reached the finish line to date. In the past 5 years, 0 clinical trials started and 0 clinical trials were completed. i.e. 0% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Oncology-Hematology of Lehigh Valley PC" #1 sponsor was "Celgene" with 2 trials, followed by "AVEO Pharmaceuticals, Inc." with 1 trials sponsored, "Eisai Inc." with 1 trials sponsored, "Hoffmann-La Roche" with 1 trials sponsored and "Novartis Pharmaceuticals" with 1 trials sponsored. Other sponsors include -4 different institutions and companies that sponsored additional 6 trials in total.

According to Clinical.Site data, the most researched conditions in "Oncology-Hematology of Lehigh Valley PC" are "Colorectal Cancer" (2 trials), "Breast Cancer" (1 trials), "Chronic Lymphocytic Leukemia" (1 trials), "Multiple Myeloma" (1 trials) and "Non-Small-Cell Lung Cancer" (1 trials). Many other conditions were trialed in "Oncology-Hematology of Lehigh Valley PC" in a lesser frequency.

Most popular intervention types in "Oncology-Hematology of Lehigh Valley PC" are "Drug" (5 trials) and "Other" (1 trials). Other intervention types were less common.

The name of intervention was led by "5-Fluorouracil (5-FU)" (1 trials), "Bevacizumab" (1 trials), "Capecitabine" (1 trials), "Leucovorin (LV)" (1 trials) and "Oxaliplatin" (1 trials). Other intervention names were less common.

The vast majority of trials in "Oncology-Hematology of Lehigh Valley PC" are 6 trials for "All" genders and 1 trials for "Female" genders.

Currently, there are NaN active trials in "Oncology-Hematology of Lehigh Valley PC". undefined are not yet recruiting, undefined are recruiting, 1 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 6 completed trials in Oncology-Hematology of Lehigh Valley PC, undefined suspended trials, and undefined terminated clinical trials to date.

Out of the total trials that were conducted in Oncology-Hematology of Lehigh Valley PC, 0 "Phase 1" clinical trials were conducted, 1 "Phase 2" clinical trials and 3 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 1 trials, and there were also 0 trials that are defined as “Not Applicable".